Literature DB >> 15379841

Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study.

W M Wong1, K C Lai, K F Lam, W M Hui, J Q Huang, H H X Xia, W H C Hu, C L K Lam, C K Chan, S K Lam, B C Y Wong.   

Abstract

BACKGROUND: The natural history of gastro-oesophageal reflux disease in Asian population has not been studied before. AIM: To study the onset and disappearances of reflux symptoms over a 1-year period in the Chinese population.
METHODS: A population-based telephone survey was performed in 2002 and repeated 1 year later. The change in prevalence rate, onset and disappearance of gastro-oesophageal reflux disease, and the change in diagnoses were assessed. Factors associated with the onset and disappearance of gastro-oesophageal reflux disease were studied.
RESULTS: A total of 712 subjects completed the first and second survey. The annual, monthly and weekly prevalence of gastro-oesophageal reflux disease were 34.1%, 10.1% and 2.7% respectively. The onset rate (per 1000 person-year) and disappearance rate of any gastro-oesophageal reflux disease and frequent gastro-oesophageal reflux disease (> or = monthly symptoms) were 209, 40; and 395, 243 respectively. Forty-four percentage of gastro-oesophageal reflux disease subjects changed their diagnoses in 2003. By multiple logistic regression analysis, high anxiety score (OR: 1.2, 95% CI: 1.1-1.2) and higher educational level (OR: 2.7, 95% CI: 1.3-6.3) were associated with the onset of gastro-oesophageal reflux disease; while the frequency of acid regurgitation (OR: 0.35, 95% CI: 0.17-0.70) and use of antisecretory therapy (OR: 0.50, 95% CI: 0.28-0.89) were associated with the disappearance of gastro-oesophageal reflux disease.
CONCLUSION: The prevalence of gastro-oesophageal reflux disease is stable over 1 year. Higher anxiety score and higher educational level were associated with the onset of gastro-oesophageal reflux disease, while lower frequency of reflux symptoms and infrequent use of antisecretory therapy were associated with the disappearance of gastro-oesophageal reflux disease in a Chinese population.

Entities:  

Mesh:

Year:  2004        PMID: 15379841     DOI: 10.1111/j.1365-2036.2004.02198.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

Review 1.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 2.  Comparative Efficacy of Antidepressants for Symptoms Remission of Gastroesophageal Reflux: A Bayesian Network Meta-analysis of Randomized Controlled Trials.

Authors:  Xiao-Bei Si; Lin-Yu Huo; De-Ying Bi; Yu Lan; Shuo Zhang
Journal:  Turk J Gastroenterol       Date:  2021-10       Impact factor: 1.852

3.  Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction.

Authors:  Ja Seol Koo; Sang Woo Lee; Sun Min Park; Sung Woo Jung; Hyung Joon Yim; Jong Jae Park; Hoon Jai Chun; Hong Sik Lee; Jai Hyun Choi; Chang Duck Kim; Ho Sang Ryu
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

4.  Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.

Authors:  Juan Zeng; Xiu-Li Zuo; Yan-Qing Li; Wei Wei; Guo-Ping Lv
Journal:  Eur J Clin Pharmacol       Date:  2007-03-20       Impact factor: 2.953

Review 5.  Gastro-oesophageal reflux disease in Asia : birth of a 'new' disease?

Authors:  Ting K Cheung; Benjamin C Y Wong; Shiu K Lam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Gastroesophageal reflux disease symptoms are more common in general practice in Japan.

Authors:  Toshiyasu Watanabe; Yoshihisa Urita; Motonobu Sugimoto; Kazumasa Miki
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

7.  Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity.

Authors:  Enrique Rey; Mónica García-Alonso; Marta Moreno-Ortega; Cristina Almansa; Angel Alvarez-Sanchez; Manuel Díaz-Rubio
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

8.  A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China.

Authors:  Jia He; Xiuqiang Ma; Yanfang Zhao; Rui Wang; Xiaoyan Yan; Hong Yan; Ping Yin; Xiaoping Kang; Jiqian Fang; Yuantao Hao; Qiang Li; John Dent; Joseph Jy Sung; Duowu Zou; Mari-Ann Wallander; Saga Johansson; Wenbin Liu; Zhaoshen Li
Journal:  BMC Gastroenterol       Date:  2010-08-15       Impact factor: 3.067

9.  Impact of gastroesophageal reflux disease on daily life: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) epidemiological study.

Authors:  Rui Wang; Duowu Zou; Xiuqiang Ma; Yanfang Zhao; Xiaoyan Yan; Hong Yan; Jiqian Fang; Ping Yin; Xiaoping Kang; Qiang Li; John Dent; Joseph J Sung; Katarina Halling; Saga Johansson; Wenbin Liu; Jia He
Journal:  Health Qual Life Outcomes       Date:  2010-11-10       Impact factor: 3.186

10.  Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.

Authors:  So Young Jo; Nayoung Kim; Ji Hwan Lim; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.